SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation Of Possible Breaches Of Fiduciary Duty By Directors Of ViroPharma Incorporated In Connection With Proposed Buyout

The securities litigation firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of ViroPharma Incorporated (“ViroPharma” or the “Company”) (NASDAQ: VPHM) and other violations of state law by the board of directors of ViroPharma relating to the proposed buyout of the Company by Shire Plc. The firm’s investigation seeks to determine, among other things, whether the board of directors of ViroPharma breached their fiduciary duties by failing to maximize shareholder value.

According to the press release announcing the proposed buyout, ViroPharma shareholders will receive $50.00 per share in cash for each share of ViroPharma common stock they own.

If you currently own common stock of ViroPharma and would like to learn more about the investigation being conducted by Brower Piven, you may email or call Brower Piven, who will, without obligation or cost to you, attempt to answer your questions. You may contact Brower Piven by email at hoffman@browerpiven.com, by calling (410) 415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and other class action cases of over 60 years.

Copyright Business Wire 2010

If you liked this article you might like

Acting FTC Chairman Says Deal with China with Carrots and Sticks

Shire Quickly Pulls Off Dermagraft

Market Up on Deals, Results

Shire Deal Just The Start

Upbeat China Data Kickstarts Week